Abstract
Chronic obstructive pulmonary disease (COPD) is a chronic, debilitating disease characterized by airflow limitations that result in significant morbidity and mortality. This chapter will review the pathophysiology of COPD, the prevalence of both the disease and its psychological comorbidities, anxiety, panic disorder, and depression and explore evidence-based treatment options.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Adshead, F., Cody, D., & Pitt, B. (1992). BASDEC: A novel screening instrument for depression in elderly medical patients. British Medical Journal, 305(6854), 648.
Aghanwa, H. S., & Erhabor, G. E. (2001). Specific psychiatric morbidity among patients with chronic obstructive pulmonary disease in a Nigerian general hospital. Journal of Psychosomatic Research, 50, 179–183.
Alexopoulos, G. S., Sirey, J. A., Raue, P. J., Kanellopoulos, D., Clark, T. E., & Novitch, R. (2006). Outcomes of depressed patients undergoing inpatient pulmonary rehabilitation. American Journal of Geriatric Psychiatry, 14, 466–475.
Almagro, P., Barreiro, B., Ochoa de Echaguen, A., Quintana, S., Carballeira, M., Heredia, J., et al. (2006). Risk factors for hospital readmission in patients with chronic obstructive pulmonary disease. Respiration, 73, 311–317.
Almagro, P., Calbo, E., Ochoa de Echaguen, A., Barreiro, B., Quintana, S., Heredia, J., et al. (2002). Mortality after hospitalization in COPD. Chest, 121(5), 1441–1448.
Almagro, P., Garcia, F., Cabrera, F., Montero, L., Morchon, D., Diez, J., et al. (2009). Comorbidity and gender-related differences in patients hospitalized for COPD, The ECCO study. Respiratory Medicine, 20, 1–7.
American Psychiatric Association. (2000). Quick reference to the diagnostic criteria from the DSM-IV-TR. Washington: American Psychiatric Association.
Anderson, F., Borg, S., Jansson, S. A., Jonsson, A. C., Ericsson, A., Prutz, C., et al. (2002). The costs of exacerbations in chronic obstructive pulmonary disease. Respiratory Medicine, 96, 700–708.
Argyropoulou, P., Patakas, D., Koukou, A., Vasiliadis, P., & Georgopoulos, D. (1993). Buspirone effect on breathlessness and exercise performance in patients with chronic obstructive pulmonary disease. Respiration, 60, 216–220.
Bailey, P. H. (2004). The dyspnea-anxiety-dyspnea cycle-COPD patients’ stories of breathlessness: “It’s scary/when you can’t breathe”. Qualitative Health Research, 14(6), 760–778.
Barbee, J. G., Billings, C. K., Bologna, N. B., & Townsend, M. H. (2003). A follow-up study of DSM-III-R generalized anxiety disorder with syndromal and subsyndromal major depression. Journal of Affective Disorders, 73(3), 229–236.
Beck, A. T. (1961). A systematic investigation of depression. Comprehensive Psychiatry, 2, 163–170.
Beck, A. T. (1978). Depression inventory. Philadelphia: Center for Cognitive Therapy.
Beck, A. T., Emery, G., & Greenberg, R. (2005). Anxiety disorders and phobias: Cognitive perspective. New York: Basic Books.
Beck, A. T., Epstein, N., Brown, G., & Steer, R. A. (1988). An inventory for measuring clinical anxiety: Psychometric properties. Journal of Consulting and Clinical Psychology, 56(6), 893–897.
Beck, A. T., Steer, R. A., & Garbin, M. G. (1988). Psychometric properties of the Beck depression inventory twenty-five years of evaluation. Clinical Psychology Review, 8, 77–100.
Beekman, A. T., Copeland, J. R., & Prince, M. J. (1999). Review of community prevalence of depression in later life. British Journal of Psychiatry, 174, 307–311.
Bejelland, I., Dahl, A., Haug, T., & Neckelmann, D. (2002). The validity of the hospital anxiety and depression scale: An updated literature review. Journal of Psychiatric Research, 52, 69–77.
Borson, S., Claypoole, K., & McDonald, G. (1998). Depression and chronic obstructive pulmonary disease: Treatment trials. Seminars in Clinical Neuropsychiatry, 3, 115–130.
Borson, S., McDonald, G. J., Gayle, T., Deffebach, M., Lakshminarayan, S., & VanTuinen, C. (1992). Improvement in mood, physical symptoms, and function with nortriptyline for depression in patients with chronic obstructive pulmonary disease. Psychomatics, 33(2), 190–201.
Bosley, C. M., Corden, Z. M., Rees, P. J., & Cochrane, G. M. (1996). Psychological factors associated with use of home nebulized therapy for COPD. The European Respiratory Journal, 9(11), 2346–2350.
Brenes, G. A. (2003). Anxiety and chronic obstructive pulmonary disease: Prevalence, impact, and treatment. Psychosomatic Medicine, 65, 963–970.
Brown, E. S., & Chandler, P. A. (2001). Mood and cognitive changes during systemic corticosteroid therapy. Primary Care Companion to The Journal of Clinical Psychiatry, 3, 17–21.
Buist, A. S., McBurnie, M. A., Vollmer, W. M., Gillespie, S., Burney, P., Mannino, D. M., et al. (2007). International variations in the prevalence of COPD (the BOLD study): A population-based prevalence study. The Lancet, 370(9589), 741–750.
Celli, B. R., Cote, C. G., Marin, J. M., Casanova, C., de Oca, M. M., Mendez, R. A., et al. (2004). The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease. The New England Journal of Medicine, 350(10), 1005–1012.
Celli, B. R., & MacNee, W. (2004). Standards for the diagnosis and treatment of patients with COPD: A summary of the ATS/ERS Task Force. The European Respiratory Journal, 23, 932–946.
Chavannes, N. H., Huibers, M. J., Schermer, T. R., Hendriks, A., van Weel, C., Wouters, E., et al. (2005). Associations of depressive symptoms with gender, body mass index, and dyspnea in primary care COPD patients. Family Practice, 22, 604–607.
Chronic Obstructive Pulmonary Disease Fact Sheet. August 2006. American Lung Association. Accessed March 8, 2007, www.lungusa.org
Connors, A. F., Dawson, N. V., Thomas, C., Harrell, F. F., Desbiens, N., Fulkerson, W. J., et al. (1996). Outcomes following acute exacerbation of severe chronic obstructive disease. American Journal of Respiratory and Critical Care Medicine, 154, 959–967.
COPD International. Accessed February 7, 2010, www.copd-international.com
Cote, C. G., & Celli, B. R. (2009). BODE index: A new tool to stage and monitor progression of chronic obstructive pulmonary disease. Pneumonologia i Alergologia Polska, 77, 305–313.
Coventry, P. A. (2009). Does pulmonary rehabilitation reduce anxiety and depression in chronic obstructive pulmonary disease? Current Opinion in Pulmonary Medicine, 15, 143–149.
Coventry, P. A., & Gellatly, J. L. (2008). Improving outcomes for COPD patients with mild-to-moderate anxiety and depression: A systematic review of cognitive behavioral therapy. British Journal of Health Psychology, 13, 381–400.
Coventry, P. A., & Hind, D. (2007). Comprehensive pulmonary rehabilitation for anxiety and depression in adults with chronic obstructive pulmonary disease: A systematic review and meta-analysis. Journal of Psychosomatic Research, 63, 551–565.
Cully, J. A., Graham, D. P., Stanley, M. A., Ferguson, C. J., Sharafkhaneh, A., Souchek, J., et al. (2006). Quality of life in patients with chronic obstructive pulmonary disease and comorbid anxiety or depression. Psychosomatics, 47(4), 312–319.
Dahlen, I., & Jansen, C. (2002). Anxiety and depression are related to the outcome of emergency treatment in patients with obstructive pulmonary disease. Chest, 122, 1633–1637.
Damarla, M., Celli, R., Mullerova, H., & Pinto-Plata, V. (2006). Discrepancy in the use of confirmatory tests in patients hospitalized with the diagnosis of chronic obstructive pulmonary disease or congestive heart failure. Respiratory Care, 51, 1120–1124.
de Godoy, D., & de Godoy, R. (2003). A randomized controlled trial of the effect of psychotherapy on anxiety and depression in chronic obstructive pulmonary disease. Archives of Physical Medicine and Rehabilitation, 84, 1154–1157.
de Godoy, R. F., Teixeira, P. J., Junior, B. B., Michellli, M., & de Godoy, D. V. (2009). Long-term repercussions of a pulmonary rehabilitation program on the indices of anxiety, depression, quality of life and physical performance in patients with COPD. Jornal Brasileiro de Pneumologia, 35(2), 129–136.
de Torres, J., Casanova, C., Hernandez, C., Abreu, J., Aquirre-Jaime, A., & Celli, B. (2005). Gender and COPD in patients attending a pulmonary clinic. Chest, 128, 2012–2016.
de Torres, J., Casanova, C., Hernandez, C., Abreu, J., Montejo de Garcini, A., & Aquirre-Jaime, A. (2006). Gender associated differences in determinants of quality of life in patients with COPD: A case series study. Health and Quality of Life Outcomes, 4, 72.
DiMarco, F., Verga, M., Reggente, M., Casanova, F., Santus, P., Blasi, F., et al. (2006). Anxiety and depression in COPD patients: The roles of gender and disease severity. Respiratory Medicine, 100, 1767–1774.
DiMatteo, M. R., Lepper, H. S., & Croghan, T. W. (2000). Depression is a risk factor for noncompliance with medical treatment: Meta-analysis of the effects of anxiety and depression on patient adherence. Archives of Internal Medicine, 160, 2101–2107.
Dowson, C., Laing, R., Barraclough, R., Town, I., Mulder, R., Norris, K., et al. (2001). The use of the Hospital Anxiety and Depression scale (HADS) in patients with chronic obstructive pulmonary disease: A pilot study. The New Zealand Medical Journal, 114, 447–449.
Eaton, W. W., Kessler, R. C., Wittchen, H. U., & Magee, W. J. (1994). Panic and panic disorder in the United States. The American Journal of Psychiatry, 151, 413–420.
Eiser, N., Harte, R., Karvounis, S., Phillips, C., & Isaac, M. (2005). Effect of treating depression on quality of life and exercise tolerance in severe COPD. Chronic Obstructive Pulmonary Disease, 2, 233–241.
Eiser, N., West, C., Evans, S., Jeffers, A., & Quirk, F. (1997). Effects of psychotherapy in moderately severe COPD: A pilot study. The European Respiratory Journal, 10, 1581–1584.
Elci, A., Borekci, S., Ovayolu, N., & Elbek, O. (2008). The efficacy and applicability of a pulmonary rehabilitation programme for patients with COPD in a secondary-care community hospital. Respirology, 13, 703–707.
Emery, C. F., Green, M. R., & Suh, S. (2008). Neuropsychiatric function in chronic lung disease: The role of pulmonary rehabilitation. Respiratory Care, 53(9), 1208–1216.
Emery, C. F., Schein, R. L., Hauck, E. R., & MacIntyre, N. R. (1998). Psychological and cognitive outcomes of a randomized trial of exercise among patients with chronic obstructive pulmonary disease. Journal of Health Psychology, 17, 232–240.
Evans, M., Hammond, M., Wilson, K., Lye, M., & Copeland, J. (1997). Placebo controlled treatment trial of depression in elderly physically ill patients. International Journal of Geriatric Psychiatry, 12, 817–824.
Fan, V. S., Giardino, N. D., Blough, D. K., Kaplan, R. M., & Ramsey, S. D. (2008). Costs of pulmonary rehabilitation and predictors of adherence in the National Emphysema Treatment Trial. Chronic Obstructive Pulmonary Disease, 5, 105–116.
Fan, V. S., Ramsey, S. D., Giardino, N. D., Make, B. J., Emery, C. F., Diaz, P. T., et al. (2007). Sex, depression, and risk of hospitalization and mortality in chronic obstructive pulmonary disease. Archives of Internal Medicine, 167(21), 2345–2353.
Foster, J. M., Aucott, L., van der Werf, R. H., van der Meijden, M. S., Schraa, G., Postma, D. S., et al. (2006). High patient perceived side effects related to higher daily doses of inhaled corticosteroids in the community: A cross-sectional analysis. Respiratory Medicine, 100, 1318–1336.
Funk, G., Kirchheiner, K., Burghuber, O. C., & Hartl, S. (2009). BODE index versus GOLD classification for explaining anxious and depressive symptoms in patients with COPD – A cross sectional study. Respiratory Research, 10, 1.
Gan, W. Q., Man, S. F., Senthilselvan, A., & Sin, D. D. (2004). Association between chronic obstructive pulmonary disease and systemic inflammation: A systematic review and meta-analysis. Thorax, 59(7), 574–580.
Gelb, A. F., & Zamel, N. (1975). Effect of aging on lung mechanics in healthy nonsmokers. Chest, 68(4), 538–541.
Gerhardsson de Verdier, M. (2008). The big three concept: A way to tackle the health care crisis? Proceedings of the American Thoracic Society, 5(8), 800–805.
Gift, A. G., Moore, T., & Soeken, K. (1992). Relaxation to reduce dyspnea and anxiety in COPD patients. Nursing Research, 41, 242–246.
Global Obstructive Lung Initiative (GOLD), updated 2009. Accessed February 7, 2010, www.goldcopd.com
Griffiths, T. L., Burr, M. L., Campbell, I. A., Lewis-Jenkins, V., Mullins, J., Shiels, K., et al. (2000). Results at 1 year of outpatient multidisciplinary pulmonary rehabilitation: A randomized controlled trial. The Lancet, 355, 362–368.
Groenewegen, K. H., Schols, A. M., & Wouters, E. F. (2003). Mortality and mortality-related factors after hospitalization for acute exacerbation of COPD. Chest, 124, 459–467.
Gudmundsson, G., Gislason, T., Janson, C., Lindberg, E., Hallin, R., Ulrik, C., et al. (2005). Risk factors rehospitalization in COPD: Role of health status, anxiety and depression. The European Respiratory Journal, 26, 414–419.
Guell, R., Casan, P., Belda, J., Sangenis, M., Morante, F., Guyatt, G., et al. (2000). Long-term effect of outpatient rehabilitation of COPD. Chest, 117, 976–983.
Guell, R., Resqueti, V., Sangenis, M., Morante, F., Martorell, B., Casan, P., et al. (2006). Impact of pulmonary rehabilitation on psychosocial morbidity in patients with severe COPD. Chest, 129, 899–904.
Halbert, R. J., Natoli, J. L., Gano, A., Badamgarav, E., Buist, A. S., & Mannino, D. M. (2006). Global burden of COPD: Systematic review and meta-analysis. The European Respiratory Journal, 28, 523–532.
Hamilton, M. (1959). The assessment of anxiety states by rating. The British Journal of Medical Psychology, 32, 50–55.
Han, M. K., Postma, D., Mannino, D. M., Giardino, N. D., Buist, S., Curtis, J. L., et al. (2007). Gender and chronic obstructive pulmonary disease: Why it matters. American Journal of Respiratory and Critical Care Medicine, 176, 1179–1184.
Hann, D., Winter, K., & Jacobson, P. (1999). Measurement of depressive symptoms in cancer patients: Evaluation of the Center for Epidemiological Studies Depression scale (CES-D). Journal of Psychiatric Research, 46, 437–443.
Heslop, K., De Soyza, A., Baker, C., Stenton, C., & Burns, G. (2009). Using individualized cognitive behavioral therapy as a treatment for people with COPD. Nursing Times, 105(14), 14–17.
Howard, C., Hallas, C., Wray, J., & Carby, M. (2009). The relationship between illness perceptions and panic in chronic obstructive pulmonary disease. Behaviour Research and Therapy, 47, 71–76.
Hurd, S. (2000). The impact of COPD on lung health worldwide: Epidemiology and incidence. Chest, 117(2 Suppl.), 1S–4S.
Hynninen, M. J., Pallesen, S., & Nordhaus, I. (2007). Factors affecting health status in COPD patients with co-morbid anxiety or depression. International Journal of Chronic Obstructive Pulmonary Disease, 2(3), 323–328.
Jemal, A., Ward, E., Hao, Y., & Thun, M. (2005). Trends in leading causes of death in the United States, 1970–2002. Journal of the American Medical Association, 294(10), 1255–1259.
Johnson, D. A., & Heather, B. B. (1974). The sensitivity of the Beck Depression Inventory to changes in symptomatology. The British Journal of Psychiatry, 125, 184–185.
Judd, L. L., Akiskal, H. S., Maser, J. D., Zeller, P. J., Endicott, J., Coryell, W., et al. (1998). A prospective 12-year study of subsyndromal and syndromal depressive symptoms in unipolar major depressive disorders. Archives of General Psychiatry, 55(8), 694–700.
Karajgi, B., Rifkin, A., Doddi, S., & Kolli, R. (1990). The prevalence of anxiety disorders in patients with chronic obstructive pulmonary disease. The American Journal of Psychiatry, 147, 200–201.
Kayahan, B., Karapolat, H., Atyntoprak, E., Atasever, A., & Ozturk, O. (2006). Psychological outcomes of an outpatient pulmonary rehabilitation program in patients with chronic obstructive pulmonary disease. Respiratory Medicine, 100, 1050–1057.
Kessler, R. C., Chiu, W. T., Demler, O., & Walters, E. E. (2005). Prevalence, severity, and comorbidity of twelve-month DSM-IV disorders in the National Comorbidity Survey Report (NCS-R). Archives of General Psychiatry, 62(6), 612–627.
Kessler, R. C., McGonagle, K. A., Zhao, S., Nelson, C. B., Hughes, M., Eshleman, S., et al. (1994). Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Archives of General Psychiatry, 51, 8–19.
Kim, H. F., Kunik, M. E., Molinari, V. A., Hillman, S. L., Lalani, S., Orengo, C., et al. (2000). Functional impairment in COPD patients: The impact of anxiety and depression. Psychosomatics, 41, 465–471.
Koenig, H. G., & Kuchibhatla, M. (1998). Use of health services by hospitalized medically ill depressed elderly patients. The American Journal of Psychiatry, 155, 871–877.
Kozora, E., Tran, Z. V., & Make, B. (2002). Neurobehavioral improvement after brief rehabilitation in patients with chronic obstructive pulmonary disease. Journal of Cardiopulmonary Rehabilitation, 22, 426–430.
Kroenke, K., Spitzer, R. L., & Williams, J. B. (2001). The PHQ-9: Validity of a brief depression screening measure. Journal of General Internal Medicine, 16(9), 606–613.
Kroenke, K., Spitzer, R. L., Williams, J. B., & Lowe, B. (2009). An ultra- brief screening tool for anxiety and depression: The PHQ-4. Psychosomatics, 50(6), 613–621.
Kumar, S., & Gross, N. J. (2002). The global initiative for COPD: What you need to know; smoking cessation is still the most effective way to reduce risk (chronic obstructive pulmonary disease). Journal of Respiratory Disease, 23(11), 549–556.
Kunik, M., Azzam, P., Souchek, J., Cully, J., Wray, N., Krishnan, L., et al. (2007). A practical screening tool for anxiety and depression in patients with chronic breathing disorders. Psychosomatics, 48, 16–21.
Kunik, M. E., Braun, U., Stanley, M. A., Wristers, K., Molinari, V., Stoebner, D., et al. (2001). One session cognitive behavioral therapy for elderly patients with chronic pulmonary disease. Psychological Medicine, 31, 717–723.
Kunik, M. E., Roundy, K., Veazey, C., Souchek, J., Richardson, P., Wray, N. P., et al. (2005). Surprisingly high prevalence of anxiety and depression in chronic breathing disorders. Chest, 127, 1205–1211.
Kunik, M. E., Veazey, C., Cully, J. A., Soucek, J., Graham, D. P., Hopko, D., et al. (2008). COPD education and cognitive behavioral therapy group treatment for clinically significant symptoms of depression and anxiety in COPD patients: A randomized controlled trial. Psychological Medicine, 38, 385–396.
Lacasse, Y., Beaudoin, L., Rousseau, L., & Maltais, F. (2004). Randomized trial of paroxetine in end-stage COPD. Monaldi Archives for Chest Disease, 61, 140–147.
Laurin, C., Lavoie, K., Bacon, S., Dupuis, G., Lacoste, G., Cartier, A., et al. (2007). Sex differences in the prevalence of psychiatric disorders with psychological distress in patients with COPD. Chest, 132, 148–155.
Lenfant, C. (2005). Medical and psychiatric illness: Different but concurrent! Metabolism, Clinical and Experimental, 54, 53–54.
Lewis, K. E., Annandale, J. A., Sykes, R. N., Hurlin, C., Owen, C., & Harrison, N. K. (2007). Prevalence of anxiety and depression in patients with severe COPD: Similar high levels with and without LTOT. Chronic Obstructive Pulmonary Disease, 4, 305–312.
Lisansky, D., & Hendel-Clough, D. (1996). A cognitive-behavioral self-help educational program for patients with COPD: A pilot study. Psychotherapy and Psychosomatics, 65, 97–101.
Livermore, N., Butler, J. E., Sharpe, L., McBain, R. A., Gandevia, S. C., & McKenzie, D. K. (2008). Panic attacks and perception of inspiratory resistive loads in chronic obstructive pulmonary disease. American Journal of Respiratory and Critical Care Medicine, 178, 7–12.
Livermore, N., Sharpe, L., & McKenzie, D. (2010). Prevention of panic attacks and panic disorder in chronic obstructive pulmonary disease. The European Respiratory Journal, 35(3), 557–563.
Lolak, S., Connors, G., Sheridan, M., & Wise, T. (2009). Effects of progressive muscle relaxation training on anxiety and depression in patients enrolled in an outpatient pulmonary rehabilitation program. Psychotherapy and Psychosomatics, 77, 119–125.
Maurer, J., Rebbapragada, V., Borson, S., Goldstein, R., Kunik, M., Yohannes, A. M., et al. (2008). Anxiety and depression in COPD: Current understanding, unanswered questions, and research needs. Chest, 134, 43S–56S.
McGeoch, G., Willsman, K., Dowson, C., Town, G., Frampton, C., & McCartin, F. (2006). Self management plans in the primary care of patients with chronic obstructive pulmonary disease. Respirology, 11, 611–618.
McNair, D. M., & Lorr, M. (1964). An analysis of mood in neurotics. Journal of Abnormal and Social Psychology, 69, 620–627.
Menzin, J., Boulanger, L., Marton, J., Guadagno, L., Dastani, H., Dirani, R., et al. (2008). The economic burden of chronic obstructive pulmonary disease (COPD) in a U.S. Medicare population. Respiratory Medicine, 102, 1248–1256.
Mikkelsen, R. L., Middelboe, T., Pisinger, C., & Stage, K. B. (2004). Anxiety and depression in patients with chronic obstructive disease (COPD). Nordic Journal of Psychiatry, 58, 65–70.
Moore, M. C., & Zebb, B. J. (1998). Functional status in chronic obstructive pulmonary disease: The moderating effect of panic. International Journal of Rehabilitation and Health, 42(2), 83–93.
Moore, M. C., & Zebb, B. J. (1999). The catastrophic misinterpretation of physiological distress. Behaviour Research and Therapy, 37, 1105–1118.
Narsavage, G. L., & Chen, K. Y. (2008). Factors related to depressed mood in adults with chronic obstructive pulmonary diseases after hospitalization. Home Health care nurse, 26(8), 447–482.
Nazir, S. A., & Erbland, M. L. (2009). Chronic obstructive pulmonary disease: An update on diagnosis and management issues in older adults. Drugs & Aging, 26(10), 813–831.
Ng, T. P., Niti, M., Tan, W. C., Cao, Z., Ong, K. C., & Eng, P. (2007). Depressive symptoms and chronic obstructive pulmonary disease: Effect on mortality, hospital readmission symptom burden, functional status, and quality of life. Archives of Internal Medicine, 167, 60–67.
Nguyen, H. Q., & Carrieri-Kohlman, V. (2005). Dyspnea self-management in patients with chronic obstructive pulmonary disease: Moderating effects of depressed mood. Psychosomatics, 46, 402–410.
Nici, L., Donner, D., Wouters, E., Zuwallack, R., Ambrosino, N., Bourbeau, J., et al. (2006). American Thoracic Society/European Respiratory Society statement on pulmonary rehabilitation. American Journal of Respiratory and Critical Care Medicine, 173, 1390–1413.
Norwood, R., & Balkissoon, R. (2005). Current perspectives on management and co-morbid depression in COPD. Chronic Obstructive Pulmonary Disease, 2, 185–193.
O’Neill, E. S. (2002). Illness representation and coping of women with chronic obstructive pulmonary disease: A pilot study. Heart & Lung, 31, 295–302.
Ormel, J., Kempen, G., Deeg, D., Brilman, E., Sondersen, E., & Relyveld, J. (1998). Functioning, well-being, and health perception in late middle-age and older people: Comparing the effects of depressive symptoms and chronic medical conditions. Journal of the American Geriatrics Society, 46, 39–48.
Ottanelli, R., Rosi, E., Ronchi, M. C., Grazzini, M., Lanini, B., Stendardi, L., et al. (2001). Perception of bronchoconstriction in smokers with airflow limitation. Clinical Science, 101(5), 515–522.
Papp, L. A., Weiss, J. R., Greenberg, H. E., Rifkin, A., Scharf, S. M., Gorman, J. M., et al. (1995). Sertraline for chronic obstructive pulmonary disease and co-morbid anxiety and mood disorders (letter to the editor). The American Journal of Psychiatry, 152, 1531.
Patten, S. B., & Williams, J. V. (2007). Chronic obstructive lung diseases and prevalence of mood, anxiety, and substance-use disorders in a large population sample. Psychosomatics, 48(6), 496–501.
Paz-Diaz, H., de Oca, M., Lopez, J., & Celli, B. (2007). Pulmonary rehabilitation improves depression, anxiety, dyspnea, and health status in patients with COPD. American Journal of Physical Medical & Rehabilitation, 86, 30–36.
Physician’s desk reference. (2009). 63rd, Florence, KY: Thomson Healthcare.
Porzelius, J., Vest, M., & Nochomovitz, M. (1992). Respiratory function, cognitions, and panic in chronic obstructive pulmonary patients. Behaviour Research and Therapy, 30, 75–77.
Puhan, M. A., Scharplatz, M., Trooster, T., & Steurer, J. (2005). Respiratory rehabilitation after acute exacerbation of COPD may reduce risk for readmission and mortality – A systematic review. Respiratory Research, 6, 54.
Quint, J. K., Baghai-Ravary, R., Donaldson, G. C., & Wedzicha, J. A. (2008). Relationship between depression and exacerbations in COPD. The European Respiratory Journal, 32(1), 53–60.
Rabe, K. F., Hurd, S., Anzueto, A., Barnes, P. J., Buist, S. A., Calverley, P., et al. (2007). Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: Gold executive summary. American Journal of Respiratory and Critical Care Medicine, 174, 532–555.
Radloff, L. S. (1977). The CES-D scale: A self-report depression scale for research in the general population. Applied Psychological Measurement, 1, 385–401.
Radloff, L. S. (1991). The use of the Center for Epidemiologic Studies Depression Scale on adolescents and your adults. Journal of Youth & Adolescence, 20, 149–166.
Raji, M. A. (2006). On depression, antidepressant medications, and resuscitation preferences in COPD patients. Chest, 129, 211.
Rapaport, M. H., & Judd, L. L. (1998). Minor depressive disorder and subsyndromal depressive symptoms: Functional impairment and response to treatment. Journal of Affective Disorder, 48(2–3), 227–232.
Ries, A. L., Kaplan, R. M., Limberg, T. M., & Prewitt, L. M. (1995). Effects of pulmonary rehabilitation on physiologic and psychosocial outcomes in patients with chronic obstructive pulmonary disease. Annals of Internal Medicine, 122, 823–832.
Rose, C., Wallace, L., Dickson, R., Ayres, J., Lehman, R., Searle, Y., et al. (2002). The most effective psychologically-based treatments to reduce anxiety and panic in patients with chronic obstructive pulmonary disease (COPD): A systematic review. Patient Education and Counseling, 47, 311–318.
Roundy, K., Cully, J., Stanley, M., Veazey, C., Souchek, J., Wray, N., et al. (2005). Are anxiety and depression addressed in primary care patients with chronic obstructive pulmonary disease? A chart review. The Journal of Clinical Psychiatry, 7, 213–220.
Roy-Byrne, P., Katon, W., Broadhead, W. E., Lepine, J. P., Richards, J., Brantley, P. J., et al. (1994). Subsyndromal (“mixed”) anxiety-depression in primary care. Journal of General Internal Medicine, 9(9), 507–512.
Sassi-Dambron, D. E., Eakin, E. G., Ries, A. L., & Kaplan, R. M. (1995). Treatment of dyspnea in COPD: A controlled clinical trial of dyspnea management strategies. Chest, 107, 724–729.
Schane, R. E., Woodruff, P. G., Dinno, A., Covinsky, M. D., & Walter, L. C. (2008). Prevalence and risk factors for depressive symptoms in persons with chronic obstructive pulmonary disease. Journal of General Internal Medicine, 23(11), 1757–1762.
Schneider, C., Jicks, S., Bothner, U., & Meier, C. R. (2010). Chronic obstructive pulmonary disease and the risk of depression. Chest, 137, 341–347.
Seemungal, T. A., Donaldson, N. V., Paul, E. A., Bestall, J. C., Jeffries, D. J., & Wedzicha, J. A. (1998). Effects of exacerbations on quality of life in patients with chronic obstructive pulmonary disease. American Journal of Respiratory and Critical Care Medicine, 157, 1418–1422.
Seung-Kim, H. F., Kunik, M. E., Molinari, V. A., Hillman, S. L., Lalani, S., Orengo, C. A., et al. (2000). Functional impairment in COPD patients: The impact of anxiety and depression. Psychosomatics, 41, 465–471.
Sigmond, A. S., & Snaith, R. P. (1983). The hospital anxiety and depression scale. Acta Psychiatrica Scandinavica, 67(6), 361–370.
Silvertooth, E. J., Doraiswamy, P. M., Clary, G. L., Babyak, M. A., Wilkerson, N., Hellegars, C., et al. (2004). Citalopram and quality of life in lung transplant recipients. Psychosomatics, 45, 271–272.
Singh, N. P., Despars, J. A., Stansbury, D. W., Avalos, K., & Light, R. W. (1993). Effects of buspirone on anxiety levels and exercise tolerance in patients with chronic airflow obstruction and mild anxiety. Chest, 103, 800–804.
Sirey, J. A., Raue, P. J., & Alexopoulos, G. S. (2007). An intervention to improve depression care in older adults with COPD. International Journal of Geriatric Psychiatry, 22, 154–159.
Smoller, J. W., Pollack, M. H., Otto, M. W., Rosenbaum, J. F., & Kradin, R. L. (1996). Panic anxiety, dyspnea, and respiratory disease: Theoretical and clinical considerations. American Journal of Respiratory and Critical Care Medicine, 154, 6–17.
Smoller, J. W., Pollack, M. H., Systrom, D., & Kradin, R. L. (1998). Sertraline effects on dyspnea in patients with obstructive airways disease. Psychosomatics, 39, 24–29.
Spielberger, C. D. (1966). Theory and research on anxiety. New York: Academic.
Spitzer, R. L., Kroenke, K., & Williams, J. B. (1999). Validation and utility of a self-report version of Prime-MD: The PHQ primary care study. Primary Care Evaluative of Mental Disorder. Patient Health Questionnaire. Journal of the American Medical Association. 282(18), 1737–1744.
Stage, K. B., Middleboe, T., & Pisinger, C. (2005). Depression and chronic obstructive pulmonary disease (COPD). Impact on survival. Acta Psychiatrica Scandinavica, 111, 320–323.
Talamo, C., de Oca, M. M., Halbert, R., Perez-Padilla, R., Jardim, J., Muino, A., et al. (2007). Diagnostic labeling of COPD in five Latin American cities. Chest, 131, 60–67.
Tashkin, D., Kanner, R., Bailey, W., Buist, S., Anderson, P., Nides, M., et al. (2001). Smoking cessation in patients with chronic obstructive pulmonary disease: A double-blind, placebo-controlled, randomized trial. The Lancet, 357, 1571–1575.
van Manen, J. G., Bindels, P. J., Dekker, F. W., Ijzermans, C. J., van der Zee, J. S., & Schade, E. (2002). Risk of depression in patients with chronic obstructive pulmonary disease and its determinants. Thorax, 57, 412–416.
van Manen, J. G., Bindels, P. J. E., IJzermans, C. J., van der Zee, J. S., Bottems, B. J. A. M., & Schade, E. (2001). Prevalence of comorbidity in patients with chronic airway obstruction and controls over the age of 40. Journal of Clinical Epidemiology, 54, 287–293.
Verburg, K., Griez, E., Meijer, J., Pois, H. (1995). Respiratory disorders as a possible predisposed factor for panic disorder. Journal of Affective Disorders, 33(2), 129–13.
Versiani, M., Moreno, R., Ramakers-van Moorsel, C. J., & Schutte, A. J. (2005). Comparison of the effects of mirtazapine and fluoxetine in severely depressed patients. CNS Drugs, 19, 137–146.
Wagena, E. J., Arrindell, W. A., Wouters, E. F., & van Schayck, C. P. (2005). Are patients with COPD psychologically distressed? The European Respiratory Journal, 26, 242–248.
Wagena, E. J., Knipschild, P. G., Huibers, M. J., Wouters, E. F., & van Schayck, C. P. (2005). Efficacy of bupropion and nortriptyline for smoking cessation among people at risk for or with chronic obstructive pulmonary disease. Archives of Internal Medicine, 165, 2286–2292.
Wamboldt, F. S. (2005). Anxiety and depression in COPD: A call (and need) for further research. Chronic Obstructive Pulmonary Disease, 2, 199–201.
Weaver, T. E., & Narsavage, G. L. (1992). Physiological variables related to functional status in chronic obstructive pulmonary disease. Nursing Research, 41, 286–291.
Weaver, T. E., Richmond, T. S., & Narsavage, G. L. (1997). An explanatory model of functional status in chronic obstructive pulmonary disease. Nursing Research, 46, 26–31.
Withers, N. J., Rudkin, S. T., & White, R. J. (1999). Anxiety and depression in severe chronic obstructive pulmonary disease: The effects of pulmonary rehabilitation. Journal of Cardiopulmonary Rehabilitation, 19, 362–365.
World Health Organization. (2010). Chronic respiratory diseases: Burden. Accessed February 7, 2010, http://www/who.int/respiratory/copd/burden/en
Xu, W., Collet, J., Shapiro, S., Lin, Y., Yang, T., Platt, R. W., et al. (2008). Independent effect of depression and anxiety on chronic obstructive pulmonary disease exacerbations and hospitalizations. American Journal of Respiratory and Critical Care Medicine, 178, 913–920.
Yellowlees, P. M., Alpers, J. H., Bowden, J. J., Bryant, G. D., & Ruffin, R. E. (1987). Psychiatric morbidity in patients with chronic airflow obstruction. The Medical Journal of Australia, 146, 305–307.
Yohannes, A. M., Baldwin, R. C., & Connolly, M. J. (2000). Depression and anxiety in elderly outpatients with chronic obstructive pulmonary disease: Prevalence and validation of the BASDEC screening questionnaire. International Journal of Psychiatry, 15, 1090–1096.
Yohannes, A. M., Baldwin, R. C., & Connolly, M. J. (2003). Prevalence of subthreshold depression in elderly patients with chronic obstructive pulmonary disease. Journal of Geriatric Psychiatry, 18(5), 412–416.
Yohannes, A. M., Baldwin, R. C., & Connolly, M. J. (2005). Predictors of 1-year mortality in patients discharged from hospital following acute exacerbation of chronic obstructive disease. Age and Ageing, 34, 491–496.
Yohannes, A. M., Connolly, M. J., & Baldwin, R. C. (2001). A feasibility study of antidepressant drug therapy in depressed elderly patients with chronic obstructive pulmonary disease. International Journal of Psychiatry, 16, 451–454.
Zandbergen, G., Bright, M., Pots, H., Fernandez, I., Dehoof, C., Gricz, E.G. (1991). Higher lifetime prevalence of respiratory diseases in panic disorder? American Journal of Psychiatry, 148(11), 1583–1585.
Zigmond, A. S., & Snaith, R. P. (1983). The hospital anxiety and depression scale. Acta Psychiatrica Scandinavica, 67, 361–370.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2011 Springer Science+Business Media, LLC
About this chapter
Cite this chapter
McCrone, S., Putnam-Casdorph, H. (2011). Psychological Co-morbidities of COPD. In: Pagoto, S. (eds) Psychological Co-morbidities of Physical Illness. Springer, New York, NY. https://doi.org/10.1007/978-1-4419-0029-6_11
Download citation
DOI: https://doi.org/10.1007/978-1-4419-0029-6_11
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4419-0030-2
Online ISBN: 978-1-4419-0029-6
eBook Packages: MedicineMedicine (R0)